News

Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...
Baylor College of Medicine and Site Tx, Inc. are collaborating to develop novel small-molecule drugs that allow for the fine-tuning of immune ...